ArticleCurrent protocols2025
An Aqueous-Compatible On-Column Approach for the Conjugation of Nucleic Acids Using Amino Modifiers.
Article in Current protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An Aqueous-Compatible On-Column Approach for the Conjugation of Nucleic Acids Using Amino Modifiers.Current protocols · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nucleic acid conjugation has emerged as a powerful strategy for enhancing the chemical and biological versatility of synthetic oligonucleotides. Solid-support synthesis of oligonucleotides provides an avenue for nucleic acid conjugation, so long as the method is inherently compatible with the synthesis cycle. Many methods exist, post-synthetically (i.e., after strand extension via the DNA synthesizer), to add ligands to the strand while it is still bound to the solid support. These, however, tend to require stringent reaction conditions (i.e., anhydrous, degassed solvents, special apparatus), making them sometimes impractical for routine use. This article describes a streamlined aqueous-compatible on-column conjugation strategy for preparing nucleic acids containing site-specific chemical modifications. This method utilizes commercially available or easily synthesized monophosphate or carboxylate-containing ligands and solid-phase synthesized oligonucleotides containing amino-modified termini. Coupling is enabled by 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and N-methylimidazole (N-MeIm) chemistry in buffered aqueous-organic mixtures. The resulting conjugates are processed using typical deprotection and solid-support cleavage protocols, purified by standard techniques such as strong anion exchange high-performance liquid chromatography (SAX-HPLC), and are characterized by mass spectrometry (MS). © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Synthesis of zidovudine 5'-O-monophosphate Basic Protocol 2: On-column phosphoramidate-mediated conjugation of 5'-O-phosphorylated AZT to 5'-amino DNA Basic Protocol 3: On-column amide-mediated conjugation of Fmoc-protected glycine to 5'-amino modified DNA Basic Protocol 4: On-column amide-mediated conjugation of potassium benzoate to 5'-amino modified RNA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.